XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for... XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States. Show more
AUSTIN, Texas, Dec. 23, 2024 (GLOBE NEWSWIRE) -- XBiotechΒ (NASDAQ: XBIT) announced today data that it is halting its clinical program in rheumatological disease while it seeks to understand the...
AUSTIN, Texas, June 18, 2024 (GLOBE NEWSWIRE) -- XBiotechΒ (NASDAQ: XBIT) announced today data from its Phase 1/Phase 2 randomized, double-blind, placebo-controlled multi-center study for...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.1109 | -31.2725925926 | 6.75 | 7 | 3.51 | 83105 | 6.45902793 | CS |
4 | -2.3509 | -33.6323319027 | 6.99 | 7.64 | 3.51 | 71514 | 6.72052583 | CS |
12 | -2.5709 | -35.6574202497 | 7.21 | 8.32 | 3.51 | 51909 | 7.05306935 | CS |
26 | -0.5409 | -10.4420849421 | 5.18 | 8.32 | 3.51 | 80435 | 6.23887729 | CS |
52 | 0.7391 | 18.9512820513 | 3.9 | 9.96 | 3.51 | 74848 | 6.63639603 | CS |
156 | -6.6309 | -58.8367346939 | 11.27 | 11.9 | 3 | 62991 | 6.1392751 | CS |
260 | -15.1609 | -76.5702020202 | 19.8 | 31.85 | 3 | 122598 | 14.12196664 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.